Newborns of GDM women receiving insulin therapy during twin pregnancies had a significantly lower rate of SGA (4.9% VS 11.5%, P = 0.014), but were more likely to have extrauterine growth restriction (OR = 3.170, 95% CI = 1.639–6.131, P < 0.001). Here, INS is linked to gestational diabetes.